We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Indian Drugmakers Divided on Proposal to Extend Exclusivity to 10 Years
Indian Drugmakers Divided on Proposal to Extend Exclusivity to 10 Years
A proposal to extend the market exclusivity of new drugs approved in India from four years to 10 is dividing the industry, as some argue that the measure would promote safety and others contend it delays generic competition.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor